MENU
+Compare
SERA
Stock ticker: NASDAQ
AS OF
Oct 21, 04:59 PM (EDT)
Price
$3.40
Change
+$0.03 (+0.89%)
Capitalization
127.89M

SERA Sera Prognostics Forecast, Technical & Fundamental Analysis

Sera Prognostics Inc is a health diagnostic company... Show more

SERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SERA with price predictions
Oct 20, 2025

SERA's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for SERA turned positive on October 20, 2025. Looking at past instances where SERA's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2025. You may want to consider a long position or call options on SERA as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SERA advanced for three days, in of 186 cases, the price rose further within the following month. The odds of a continued upward trend are .

SERA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SERA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SERA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.449) is normal, around the industry mean (61.815). P/E Ratio (0.000) is within average values for comparable stocks, (37.952). SERA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.714). SERA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). SERA's P/S Ratio (1250.000) is slightly higher than the industry average of (81.090).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SERA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
SERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SERA is expected to report earnings to rise 43.75% to -23 cents per share on November 05

Sera Prognostics SERA Stock Earnings Reports
Q3'25
Est.
$-0.23
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.01
The last earnings report on August 06 showed earnings per share of -15 cents, beating the estimate of -23 cents. With 41.55K shares outstanding, the current market capitalization sits at 127.89M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
2749 East Parleys Way
Phone
+1 801 990-0520
Employees
57
Web
https://www.seraprognostics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QUAN0.110.01
+14.77%
Quantum International Corp
CIBH35.280.32
+0.93%
CIB Marine Bancshares, Inc.
LGGNY15.890.06
+0.38%
Legal & General Group Plc
HOYFF33.60N/A
N/A
Huhtamaki Oy
PMETF2.58-0.36
-12.19%
PMET Resources Inc.

SERA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SERA has been loosely correlated with VAPO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SERA jumps, then VAPO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SERA
1D Price
Change %
SERA100%
+5.31%
VAPO - SERA
41%
Loosely correlated
N/A
UTMD - SERA
29%
Poorly correlated
+2.24%
AMIX - SERA
28%
Poorly correlated
N/A
CORBF - SERA
27%
Poorly correlated
+7.14%
NNOX - SERA
26%
Poorly correlated
+5.76%
More

Groups containing SERA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SERA
1D Price
Change %
SERA100%
+5.31%
Medical/Nursing Services
industry (219 stocks)
19%
Poorly correlated
+47.96%
Health Services
industry (426 stocks)
-0%
Poorly correlated
+24.80%